The DOI matches its Crossref record; 28 of the 28 references it cites were found in a registry or an index.
Bone turnover in postmenopausal osteoporosis. Effect of calcitonin treatment.
Open accessAbstract
UNLABELLED: To investigate the effectiveness of calcitonin treatment of postmenopausal osteoporosis in relation to bone turnover, we examined 53 postmenopausal osteoporotic women before and after one year of therapy with salmon calcitonin (sCT), at the dose of 50 IU every other day. Baseline evaluation revealed that 17 (32%) patients had high turnover (HTOP), and 36 (68%) normal turnover osteoporosis (NTOP) as assessed by measurement of whole body retention (WBR) of 99mTc-methylene diphosphonate. The two groups did not differ in terms of bone mineral content (BMC) measured by dual photon absorptiometry at both lumbar spine and femoral diaphysis. However, HTOP patients had higher levels of serum osteocalcin (OC) and urinary hydroxyproline excretion (HOP/Cr). Multivariate regression analysis showed no correlation between parameters of bone turnover (WBR, OC, HOP/Cr) and both femoral and vertebral bone density; the latter being negatively correlated only with the years elapsed since menopause (R2 = 0.406). Treatment with sCT resulted in a significant increase of vertebral BMC in the 53 patients taken as a whole group (+/- 7%, P less than 0.001). When the results obtained in HTOP and NTOP were analyzed separately, only those with HTOP showed a marked increment of spinal BMC (+22%, P less than 0.001), NTOP subjects neither gained nor lost bone mineral during the study. Femoral BMC decreased in the whole group after sCT therapy (-3%, P less than 0.003). However, HTOP patients maintained initial BMC values, whereas those with NTOP lost a significant amount of bone during the study period (-5%, P less than 0.001). The increase of vertebral bone mass was associated with a marked depression of bone turnover detectable in both subsets of patients and in the whole group. IN CONCLUSION: (a) assessment of bone turnover cannot help predict the severity of bone loss in postmenopausal osteoporosis; (b) calcitonin therapy appears to be particularly indicated for patients with high-turnover osteoporosis, resulting in a net gain of bone mineral in the axial skeleton and a slowing of bone loss in the appendicular bones.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Riggs, B. L., Wahner, H. W., Dunn, W. L., Mazess, R. B., Offord, K. P., & Melton, L. J. (1981) · Journal of Clinical Investigation · doi:10.1172/jci110039 · Cited by 1,194
A specific method for the analysis of hydroxyproline in tissues and urine
Prockop, D. J., & Udenfriend, S. (1960) · Analytical Biochemistry · doi:10.1016/0003-2697(60)90050-6 · Cited by 1,056
SERUM BONE GLA-PROTEIN: A SPECIFIC MARKER FOR BONE FORMATION IN POSTMENOPAUSAL OSTEOPOROSIS
Brown, J. P., Malaval, L., Chapuy, M. C., Delmas, P. D., Edouard, C., & Meunier, P. J. (1984) · The Lancet · doi:10.1016/s0140-6736(84)92506-6 · Cited by 668
GENANT, H. K., CANN, C. E., ETTINGER, B., & GORDAN, G. S. (1982) · Annals of Internal Medicine · doi:10.7326/0003-4819-97-5-699 · Cited by 656
Menopausal changes in bone remodeling.
Heaney, R. P., Recker, R. R., & Saville, P. D. (1978) · PubMed · Cited by 435
Calcitonin: Physiology and Pathophysiology
Austin, L. A., & Heath, H. (1981) · New England Journal of Medicine · doi:10.1056/nejm198101293040505 · Cited by 420
Parfitt, A. M. (1982) · Metabolic Bone Disease and Related Research · doi:10.1016/0221-8747(82)90002-9 · Cited by 399
Sex steroids and bone mass. A study of changes about the time of menopause.
Slemenda, C., Hui, S. L., Longcope, C., & Johnston, C. C. (1987) · Journal of Clinical Investigation · doi:10.1172/jci113201 · Cited by 343
Long-term calcitonin therapy in postmenopausal osteoporosis
Gruber, H. E., Ivey, J. L., Baylink, D. J., Matthews, M., Nelp, W. B., Sisom, K., & Chesnut, C. H. (1984) · Metabolism · doi:10.1016/0026-0495(84)90187-2 · Cited by 329
Quantum concept of bone remodeling and turnover: Implications for the pathogenesis of osteoporosis
Parfitt, A. M. (1979) · Calcified Tissue International · doi:10.1007/bf02441211 · Cited by 275
Mazzuoli, G. F., Passeri, M., Gennari, C., Minisola, S., Antonelli, R., Valtorta, C., Palummeri, E., Cervellin, G. F., Gonnelli, S., & Francini, G. (1986) · Calcified Tissue International · doi:10.1007/bf02556587 · Cited by 218
Self-citationTotal bone calcium in normal women: Effect of age and menopause status
Gallagher, J. C., Goldgar, D., & Moy, A. (1987) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.5650020605 · Cited by 214
Reginster, J. Y., Albert, A., Lecart, M. P., Lambelin, P., Denis, D., Deroisy, R., Fontaine, M. A., & Franchimont, P. (1987) · The Lancet · doi:10.1016/s0140-6736(87)92619-5 · Cited by 202
Effect of Calcitonin and Glucocorticoids in Combination on the Hypercalcemia of Malignancy
BINSTOCK, M. L., & MUNDY, G. R. (1980) · Annals of Internal Medicine · doi:10.7326/0003-4819-93-2-269 · Cited by 199
DIFFERENCES IN SERUM BONE GLA PROTEIN WITH AGE AND SEX
Epstein, S., Mcclintock, R., Bryce, G., Poser, J., Johnston, C., & Hui, S. (1984) · The Lancet · doi:10.1016/s0140-6736(84)90360-x · Cited by 194
The use of whole-body retention of Tc-99m diphosphonate in the diagnosis of metabolic bone disease.
Fogelman, I., Bessent, R. G., Turner, J. G., Citrin, D. L., Boyle, I. T., & Greig, W. R. (1978) · PubMed · Cited by 192
Whyte, M. P., Bergfeld, M. A., Murphy, W. A., Avioli, L. V., & Teitelbaum, S. L. (1982) · The American Journal of Medicine · doi:10.1016/0002-9343(82)90810-5 · Cited by 182
Self-citationCivitelli, R., Agnusdei, D., Nardi, P., Zacchei, F., Avioli, L. V., & Gennari, C. (1988) · Calcified Tissue International · doi:10.1007/bf02556338 · Cited by 155
Self-citationWener, J. A., Gorton, S., & Raisz, L. G. (1972) · Endocrinology · doi:10.1210/endo-90-3-752 · Cited by 151
Nordin, B. E. C., Speed, R. M., Aaron, J., & Crilly, R. G. (1981) · The Lancet · doi:10.1016/s0140-6736(81)90526-2 · Cited by 112
Effects of age and menopause on vertebral bone density.
Hui, S. L., Slemenda, C. W., Johnston, C. C., & Appledorn, C. R. (1987) · PubMed · Cited by 106
Skeletal uptake of diphosphonate: A review
Fogelman, I. (1980) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/bf00252034 · Cited by 90
Age changes in the bone mineral of the lumbar spine in normal women
HANSSON, T. H., & ROOS, B. (1986) · Calcified Tissue International · doi:10.1007/bf02556602 · Cited by 80
SKELETAL UPTAKE OF DIPHOSPHONATE
Fogelman, I., COHEN, H. N., Bessent, R. G., Hart, D. M., & Lindsay, R. S. (1980) · The Lancet · doi:10.1016/s0140-6736(80)92707-5 · Cited by 68
Bone turnover in spinal osteoporosis
Pødenphant, J., Johansen, J. S., Thomsen, K., Riis, B. J., Leth, A., & Christiansen, C. (1987) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.5650020606 · Cited by 57
Estimation of Skeletal Involvement in Primary Hyperparathyroidism
Fogelman, I., Bessent, R. G., Beastall, G. H., & Boyle, I. T. (1980) · Annals of Internal Medicine · doi:10.7326/0003-4819-92-1-65 · Cited by 45
Thomsen, K., Riis, B. J., & Christiansen, C. (1986) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.5650010604 · Cited by 19
Hiyldstrup, L., McNair, P., JENSEN, G. F., Mogensen, N., & Transbøl, I. (1984) · Scandinavian Journal of Clinical and Laboratory Investigation · doi:10.3109/00365518409083629 · Cited by 19
Cited by
Bone metabolism and disease in chronic kidney disease
Eknoyan, G., Levin, A., & Levin, N. W. (2003) · American Journal of Kidney Diseases · doi:10.1016/s0272-6386(03)00905-3 · Cited by 1,286
Effects of Tamoxifen on Bone Mineral Density in Postmenopausal Women with Breast Cancer
Love, R. R., Mazess, R. B., Barden, H. S., Epstein, S., Newcomb, P. A., Jordan, V. C., Carbone, P. P., & DeMets, D. L. (1992) · New England Journal of Medicine · doi:10.1056/nejm199203263261302 · Cited by 1,129
Treatment of Postmenopausal Osteoporosis with Transdermal Estrogen
Lufkin, E. G., Wahner, H. W., O'Fallon, W. M., Hodgson, S. F., Kotowicz, M. A., Lane, A. W., Judd, H. L., Caplan, R. H., & Riggs, B. L. (1992) · Annals of Internal Medicine · doi:10.7326/0003-4819-117-1-1 · Cited by 810
The Prevention and Treatment of Osteoporosis
Wood, A. J. J., Riggs, B. L., & Melton, L. J. (1992) · New England Journal of Medicine · doi:10.1056/nejm199208273270908 · Cited by 754
Clinical and Anthropometric Correlates of Bone Mineral Acquisition in Healthy Adolescent Girls*
KATZMAN, D. K., BACHRACH, L. K., CARTER, D. R., & MARCUS, R. (1991) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-73-6-1332 · Cited by 734
Metadata
- Authors
- Civitelli, R., Gonnelli, S., Zacchei, F., Bigazzi, S., Vattimo, A., Avioli, L. V., & Gennari, C.
- Venue
- Journal of Clinical Investigation
- Published
- 1988-10-01
- Volume
- 82
- Issue
- 4
- Pages
- 1268-1274
- ISSN
- 0021-9738 (ISSN-L)
- OpenAlex
- W2124441769
- Cited by
- 358
- References
- 28
- FWCI
- 18.05
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.